Think Ophthalmology. Think Ora.

The world’s leading, full-service ophthalmic research organization

For over 40 years, Ora has been on the leading edge of ophthalmic product development. We have a track record for accelerating development timelines and have helped our clients garner 47 product approvals. Let’s work together to move your program forward.

Learn More

Who We Are

Ora was founded on a dedication to advancements and innovations in ophthalmology. For over 40 years, we have been on the cutting edge of ophthalmic product development.

Hover over the tiles to learn more.

Some of Our Clients

Executive Team

Jeanne Hecht

Chief Executive Officer

Jim Golando

Chief Operating Officer

Pia Olson

Chief Human Resources Officer

Naz Haji

Chief Digital Officer

Andrew Warner

Corporate Counsel

Sally Tucker

Head of EU Operations

Jack Crowley

Chief Financial Officer

Global Presence

Local teams around the world with the experience you need for

successful product development

Hover over map to learn more.

Comprehensive support

Offices in North America, Europe, Asia, and Australia

International experts are there to help throughout the entire product development lifecycle

Ora team members in over 15 countries

Ophthalmology is Our Only Focus and Priority

Ophthalmology is Our Only Focus and Priority

Click on the tiles to learn more.

Anterior Segment

Extensive experience supporting our customers across various indications

Read More

Posterior Segment

Industry leader in IRDs, Wet/Dry

AMD, and Glaucoma

Read More

Anterior Segment

Extensive experience supporting our customers across various indications

Read More

Recent Global Ophthalmic Experience

Indications

Click the buttons below to learn about each indication's totals from the last 5 years.

Blepharitis

Conjunctival Redness

Device

Refractive (Hyperopia/ Myopia/Presbyopia)

Dry Eye

Retina – DME

Glaucoma

Retina – PDR, RP, RVO, LCA

Ocular Allergy

Uveitis

Retina – AMD

Viral Conjunctivitis

Cataract Surgery (post-op inflammation/pain)

Sites

42

Site Locations

US

Enrolled Subjects

1438

Phases

0,2,3

Early Engagement Support

Click on each tab to learn more

Preclinical Services

Preclinical Services

Milestone data to make important decisions in the early stages of product development

Compound identification for ophthalmic utility

Ophthalmic formulation guidance

PK, ocular irritation (safety studies)

Animal efficacy models spanning a wide range of

ophthalmic diseases

Customized study design, depending on compound,

indication and MOA

Development and management of GLP toxicology

programs to support regulatory filings

Investing in Novel Endpoints

Innovating to bring advanced solutions to customers and patients

Ora CAE® Dry Eye Challenge

Ora-CAC Allergen Model & Allergen BioCube Allergy Chamber

Ora-VNC™ Mobility Courses

Ora-VNC™ Mobility Courses

Dry AMD

Endpoints

EyeCup™ Smartphone Device

Mobile units that create environment where the ocular surface is stressed to react to humidity, temperature, airflow and visual tasking

Provide endpoints that demonstrate change with intervention

Identify and enroll the appropriate patient population

OraNet™ Exclusive Site Network

Accelerate study start-up and patient recruitment

OraNet™ expands access to the pool of qualified ophthalmology specialists available to conduct clinical trials

Access established networks of patients to find the right population for your study

OraNet™ exclusive partnerships enable higher enrollment with customized recruiting plans

OraNet™ exclusive partnerships enable higher enrollment with customized recruiting plans

Extensive prescreening

of practice patients.

Support site chart review for newly diagnosed patients

Block Enrollment Strategy

Unparalleled access to ophthalmic patients

Pre-schedule

patients

Enroll more

patients per site

Reduced data

variability

accelerate your

timelines

Minimize variability of data and get insights into how and when enrollment numbers will be met – before your study even starts

Clinical Services

Clinical Trial Operations

Monitoring

Biostatistics & Data Management

Additional Services

Empowering Real-Time Management and Reporting/Metrics

96

%

Study start-up

Conduct

Systems

Track study start-up using key milestones available to you

Key process steps

IRB submission complete

First study site initiated

IP release approval

Key data

Greenlight process

Site feasibility, selection, and negotiation/

administration of contracts

Tailored Medical and Clinical Monitoring Approaches

Clinical Trial Operations

Monitoring

Biostatistics & Data Management

Additional Services

Expert Clinical Data Services

Click on the tiles to learn more.

EDC & DATA MANAGEMENT

Upholding the highest standards of data quality, integrity, and security

Read More

BIOSTATISTICS

Experts in designing and analyzing ophthalmic clinical trials

Read More

IRT

Interactive Response Technology (IRT) solutions for complex study needs

Read More